PTC THERAPEUTICS, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2012 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Ptc Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2012 to Q3 2024.
Ptc Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $19.8M, a 26.7% decline year-over-year.
Ptc Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $73.9M, a 34.3% decline year-over-year.
Ptc Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $102M, a 7.88% decline from 2022.
Ptc Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $110M, a 6.59% increase from 2021.
Ptc Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $104M, a 47.2% increase from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$73.9M	$19.8M	-$7.19M	-26.7%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$81.1M	$19.2M	-$10.1M	-34.5%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$91.2M	$18.4M	-$10.4M	-36.2%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-04-25
Q4 2023	$102M	$16.5M	-$10.8M	-39.6%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-29
Q3 2023	$112M	$26.9M	-$1.73M	-6.03%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-07
Q2 2023	$114M	$29.4M	+$1.64M	+5.92%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-08
Q1 2023	$113M	$28.8M	+$2.23M	+8.37%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-04-25
Q4 2022	$110M	$27.3M	+$1.11M	+4.22%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-29
Q3 2022	$109M	$28.7M	+$2.8M	+10.8%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-10-26
Q2 2022	$106M	$27.7M	+$2.03M	+7.9%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-03
Q1 2022	$104M	$26.6M	+$882K	+3.43%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-04-27
Q4 2021	$104M	$26.2M	+$4.82M	+22.5%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-29
Q3 2021	$98.7M	$25.9M	+$9.09M	+54.2%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-10-27
Q2 2021	$89.6M	$25.7M	+$8.79M	+52%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-04
Q1 2021	$80.8M	$25.7M	+$10.5M	+68.9%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-03
Q4 2020	$70.3M	$21.4M	+$9.95M	+86.8%	Oct 1, 2020	Dec 31, 2020	10-K	2023-02-21
Q3 2020	$60.4M	$16.8M	+$6.3M	+60%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-10-28
Q2 2020	$54.1M	$16.9M	+$5.99M	+54.9%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-07-29
Q1 2020	$48.1M	$15.2M	+$5.96M	+64.3%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-04
Q4 2019	$42.1M	$11.5M	+$2.99M	+35.3%	Oct 1, 2019	Dec 31, 2019	10-K	2022-02-22
Q3 2019	$39.1M	$10.5M	+$1.54M	+17.2%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-10-29
Q2 2019	$37.6M	$10.9M	+$2.84M	+35.1%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-05
Q1 2019	$34.8M	$9.26M	+$1.52M	+19.6%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-04-30
Q4 2018	$33.3M	$8.48M	+$2M	+30.9%	Oct 1, 2018	Dec 31, 2018	10-K	2021-02-25
Q3 2018	$31.3M	$8.94M	+$1.77M	+24.7%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-10-30
Q2 2018	$29.5M	$8.08M	+$199K	+2.52%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-06
Q1 2018	$29.3M	$7.75M	-$1.28M	-14.2%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-02
Q4 2017	$30.6M	$6.48M	-$1.92M	-22.9%	Oct 1, 2017	Dec 31, 2017	10-K	2020-03-02
Q3 2017	$32.5M	$7.17M	-$1.79M	-20%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-05
Q2 2017	$34.3M	$7.89M	-$851K	-9.74%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-07
Q1 2017	$35.1M	$9.03M	+$114K	+1.28%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-09
Q4 2016	$35M	$8.4M	+$550K	+7.01%	Oct 1, 2016	Dec 31, 2016	10-K	2019-03-01
Q3 2016	$34.5M	$8.96M	+$905K	+11.2%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-02
Q2 2016	$33.6M	$8.74M	+$408K	+4.9%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-09
Q1 2016	$33.1M	$8.92M	-$833K	-8.55%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-08
Q4 2015	$34M	$7.85M	+$1.14M	+17%	Oct 1, 2015	Dec 31, 2015	10-K	2018-03-06
Q3 2015	$32.8M	$8.05M	+$3.43M	+74.3%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-03
Q2 2015	$29.4M	$8.33M	+$4.05M	+94.7%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-04
Q1 2015	$25.4M	$9.75M	+$6.04M	+163%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-05
Q4 2014	$19.3M	$6.71M	+$3.42M	+104%	Oct 1, 2014	Dec 31, 2014	10-K	2017-03-16
Q3 2014	$15.9M	$4.62M	+$1.98M	+75%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-09
Q2 2014	$13.9M	$4.28M	+$2.4M	+127%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-07-31
Q1 2014	$11.5M	$3.71M	+$3.08M	+497%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-05
Q4 2013	$8.43M	$3.29M			Oct 1, 2013	Dec 31, 2013	10-K	2016-02-29
Q3 2013		$2.64M	+$2.12M	+407%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-06
Q2 2013		$1.88M			Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-07
Q1 2013		$621K			Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-06
Q3 2012		$520K			Jul 1, 2012	Sep 30, 2012	10-Q	2013-11-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.